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Abstract  Posterior  reversible  encephalopathy  syndrome  (PRES)  is  a  rare  but  severe  condition
of the  central  nervous  system.  It  develops  in  a  variety  of  clinical  settings  and  it  has  diverse
patterns of  expression,  which  can  sometimes  make  diagnosis  difﬁcult.  Characteristic  features
are often  demonstrated  on  computed  tomography  imaging  and/or  magnetic  resonance  imaging,
meaning  that  when  there  is  a  suspicious  clinical  picture,  this  diagnosis  should  suggest  itself.Imaging  features However, clinicians  should  be  aware  of  some  of  the  less  typical  features  in  order  to  more  fully
understand this  condition,  in  which  early  treatment  is  key  to  good  clinical  progress.
© 2012  Published  by  Elsevier  Masson  SAS  on  behalf  of  the  Éditions  françaises  de  radiologie.
Introduction
Posterior  reversible  encephalopathy  syndrome  (PRES)  is  a  radiological  and  clinical  entity
in  which  reversible  changes  occur  in  the  central  nervous  system,  associated  with  typical
features  on  MR  or  CT  brain  imaging.  Clinical  presentations  of  this  syndrome  vary  widely  as
do  the  imaging  features,  which  may  sometimes  be  atypical.  Management  may  therefore
be  delayed  due  to  protracted  diagnosing  or  an  incorrect  diagnosis.  The  aim  of  this  review
of  the  description  and  interpretation  of  imaging  ﬁndings  is  to  present  the  various  settings
in  which  this  condition  develops  and  its  patterns  of  expression,  as  well  as  describing  the
typical  and  atypical  CT  and  MRI  radiological  features.  This  is  because  in  this  condition,
the  clinical  picture  must  be  suggestive  of  the  diagnosis,  which  can  then  be  conﬁrmed  by
imaging.  This  means  that  the  factors  favouring  the  development  of  PRES  can  be  addressed
and  the  inherent  complications  of  a  delayed  diagnosis  can  be  avoided.
Abbreviations: CT, Computed tomography; MRI, Magnetic resonance imaging; SBP, Systolic blood pressure.
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Table  1 Clinical  features  of  patients  with  posterior  reversible  encephalopathy  syndrome  (PRES).
Settings  in  which  PRES  may  be  likely  to  develop  Clinical  presentations
Arterial  hypertension  Headaches
Pre-eclampsia Confusion
Transplant:  allogeneic  bone  marrow  transplant  or  solid  organ  transplant Nausea,  vomiting
Immunosuppressant  medication:  ciclosporin,  tacrolimus,  etc.  Generalised  seizures,  sometimes  with
status  epilepticus
Septicaemia,  severe  infections,  often  with  a  state  of  shock  and  multiple
organ  dysfunction  syndrome
Cerebellar  syndrome
Autoimmune  disease:  systemic  lupus  erythematosus,  scleroderma,
Wegener’s  granulomatosis
Cortical  blindness,  hemianopia,  blurred
vision
Cancer  chemotherapy:  cisplatin,  etc. Hemiparesis
Chronic  renal  failure  and  dialysis Coma
Figure 1. Male aged 36, on dialysis, who had presented static cerebellar syndrome associated with vomiting and drowsiness, preceded by
headaches and amaurosis, against a background of hypertension (systolic blood pressure of 200 mmHg). Once his elevated blood pressure
had been treated the patient quickly made good clinical progress. The initial MRI showed typical symmetrical holohemispheric involvement
(FLAIR sequences, coronal views): a: high signal intensity in the frontal lobes; b: high signal intensity in the parietal lobes and the brain
s and cerebellum; d: high signal intensity in the occipital lobes.tem; c: high signal intensity in the parietal lobes, temporal lobes 
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Figure 2. Female aged 31, on dialysis, who had presented with her ﬁrst partial epileptic seizure against a background of hypertension
(systolic blood pressure of 230 mmHg). The MRI showed characteristic diffuse, bilateral, posterior lesions. The neurological signs quickly
disappeared after anti-hypertensive treatment: a: T1-weighted axial view: low signal intensity occipital lesions; b: T2-weighted axial view:
high signal intensity occipital lesions; c: axial view on FLAIR sequence: high signal intensity occipital lesions; d and e: axial views — diffusion-
weighted sequence: the apparent diffusion coefﬁcient mapping in grey and in colour shows high signal intensity from the lesions pointing
to a raised diffusion coefﬁcient; f: 3D MR angiography: eliminates the differential diagnosis of cerebral thrombophlebitis by demonstrating
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Clinical features
Settings in which posterior reversible
encephalopathy  syndrome may be  likely to
develop
There  are  a  number  of  factors  that  favour  the  development
of  PRES  (Table  1):
• arterial  hypertension:  this  is  the  classic  setting  and
it  was  the  ﬁrst  factor  to  be  described  (hypertensive
encephalopathy).  Moderately  to  severely  elevated  blood
pressure  is  reported  in  75%  of  patients  [1,2];
• eclampsia  or  pre-eclampsia:  this  link  has  often  been
drawn  [3],  even  in  women  with  normal  blood  pressure.
Late  development  of  this  condition  has  been  reported,  as
late  as  several  weeks  after  the  birth  [3];
• chemotherapy  regimens  [4]  and  organ  transplants  that
require  patients  to  use  immunosuppressant  medications
[1,3,5],  especially  allogeneic  bone  marrow  transplants;
n
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[septicaemia  and  severe  infections,  sometimes  resulting  in
organ  dysfunction  [6];
chronic  renal  failure  and  dialysis  [7];
autoimmune  diseases:  systemic  lupus  erythematosus,
scleroderma,  Wegener’s  granulomatosis,  etc.  [8].  This
link  has  often  been  found,  even  during  periods  when
patients  are  not  being  treated  with  immunosuppressant
drugs.
linical presentations
here  are  a  range  of  neurological  presentations  that  often
nvolve  generalised  seizures,  sometimes  complicated  by  sta-
us  epilepticus,  in  combination  with  headaches,  confusion,
ausea  and  vomiting  [1,2]. There  may  be  a focal  neurologi-
al  deﬁcit,  such  as  cortical  blindness,  cerebellar  syndrome,
r  hemiparesis  [1,2]. These  presentations  may  lead  to  coma
1].
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Figure 3. A 55-year-old female who had undergone an allogeneic bone marrow transplant for myelodysplastic syndrome complicated by
gastrointestinal graft versus host disease (GVH) treated with ciclosporin. She presented several generalised seizures while in a persistent
vegetative state. Ciclosporin was continued in spite of posterior reversible encephalopathy syndrome. Neurological problems including
drowsiness, ﬂapping tremor and hyperreﬂexia persisted intermittently until the death of the patient a few days later, due to complications
of GVH. The initial MRI showed a typical holohemispheric pattern (axial views in a FLAIR sequence): a: high signal intensity in the cerebellum
and temporal lobes; b: high signal intensity in the brain stem; c: high signal intensity in the right frontal sulcus and parietal and occipital
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ypical imaging features
n  imaging,  posterior  reversible  encephalopathy  syndrome
s  characterised  by  abnormalities  of  the  white  matter  and
he  grey  matter,  predominantly  affecting  the  posterior
egions.
adiological appearance
n  computed  tomography,  diffuse  hypodense  areas  indicate
he  affected  regions.  On  MRI,  lesions  appear  as  iso-intense  or
ow  signal  intensity  on  T1-weighted  images,  and  high  signal
ntensity  on  T2-weighted  images  and  FLAIR.  Enhancement  is
ot  usually  seen  after  injection  of  a  contrast  agent.opography
he  typical  appearance  is  of  diffuse  cortical,  subcortical
nd  deep  lesions.  It  is  usually  the  posterior  regions  that
s
p
t
O lobes and the basal ganglia; e: asymmetrical parietal high signal
re  affected:  the  parietal  or  occipital  lobes  are  involved
n  98%  of  cases.  However,  the  lesions  can  also  affect  the
rontal  lobes  (68%),  the  temporal  lobes  (40%)  and  the
erebellar  hemispheres  (30%)  [9].  Three  major  distribution
atterns  were  identiﬁed  by  Bartynski  et  al.  [9]:  holohemi-
pheric  involvement  (Fig.  1)  in  23%  of  cases,  involvement
ainly  along  the  superior  frontal  sulcus  in  27%  of  cases,
nd  predominantly  parietal  and  occipital  involvement  in
2%  of  cases.  A  bilateral  and  symmetrical  appearance  is
ighly  typical  although  lesions  were  asymmetrical  in  28%  of
ases.
iffusion-weighted imaging
n  diffusion-weighted  imaging,  an  increase  in  the  diffu-
ion  coefﬁcient  (Fig.  2)  can  be  seen,  connected  to  the
resence  of  a  vasogenic  oedema  secondary  to  a  dysfunc-
ion  of  the  cerebrovascular  autoregulation  mechanisms.
ne  theory  of  the  mechanism  is  of  a  toxic  endothelial
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Figure 4. A 34-year-old woman undergoing induction chemotherapy for acute lymphoid leukaemia, treated with intrathecal methotrexate
injections, who had presented with sudden right hemiparesis against a background of elevated blood pressure (systolic blood pressure of
200 mmHg). The clinical signs regressed in a few hours: a and b: initial axial view CT without contrast injection showing (a) occipital
hypodense areas and (b) bilateral parietal hypodense areas as well as a left parietal haematoma; c and d: axial view MRI repeated after
2 months showing (a) the absence of abnormalities of the residual signal on a FLAIR sequence and (b) left parietal low signal intensity on
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vT2-weighted gradient echo from sequelae of haemorrhage.
dysfunction  leading  to  vasculopathy.  The  predominance  of
posterior  involvement  is  explained  by  the  sympathetic  ner-
vous  system  having  less  signiﬁcant  action  on  this  area,  and
the  sympathetic  neurogenic  response  is  supposed  to  com-
pensate  for  any  deterioration  in  the  myogenic  response
related  to  vascular  endothelial  injury  [10]. Given  that
this  vasogenic  oedema  is  reversible,  patients  normally
make  good  progress  after  aetiological  factors  have  been
addressed.
Angiography and perfusion imagingSome  recent  studies  have  aimed  to  evaluate  lesions  in
terms  of  changes  on  angiography  [11,12]  in  order  to  identify
the  mechanisms  causing  PRES  to  develop.  Angiography
demonstrates  vascular  irregularities  with  focal  and  diffuse
t
p
i
pasoconstriction  and  focal  vasodilation  often  producing  a
tring-of-beads  appearance,  even  in  patients  without  signif-
cant  hypertension.  Perfusion  imaging  shows  a  reduction  in
elative  cerebral  blood  volume,  which  points  to  a  mechanism
nvolving  cerebral  hypoperfusion.  In  addition,  vasogenic
edema  was  less  signiﬁcant  in  hypertensive  patients  than  in
ormotensive  patients  due  to  a chronic  adaptation  mech-
nism  of  intravascular  hyperpressure.  These  features  on
ngiography  suggest  that  the  mechanism  causing  PRES
ould  begin  with  endothelial  damage  leading  to  vascu-
opathy,  which  then  causes  cerebral  hypoperfusion  and
asogenic  oedema  followed  by  cerebral  ischaemia.  A  pro-
ective  effect  against  the  spread  of  lesions  could  be
ostulated  for  hypertension  in  the  acute  stage  of  PRES,
n  that  it  allows  a  sufﬁcient  cerebral  blood  ﬂow  to  be
reserved.
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Figure 5. A 51-year-old female, being monitored for dermatopolymyositis treated with corticosteroids and antiphospholipid syndrome,
treated with long-term vitamin K antagonists. She also had chronic renal failure (clearance of 40 mL/min). She had presented with her ﬁrst
two generalised seizures, complicated by status epilepticus. The patient quickly made good clinical progress: a and b: initial axial view
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aLAIR sequence MRI showing symmetrical high signal intensity in th
LAIR sequence MRI of the same plane 17 days later showing that t
typical presentations
here  are  some  more  atypical  radiological  features  that  clin-
cians  should  be  aware  of.
In  rarer  cases,  the  lesions  can  extend  to  the  basal  gan-
lia  (14%),  the  brain  stem  (13%)  (Fig.  3)  and  the  deep  white
atter,  in  particular  the  splenium  of  the  corpus  callosum
10%)  [9].  Even  though  involvement  is  unilateral,  this  must
ot  mean  that  the  diagnosis  does  not  stand.
In  some  severe  forms,  the  progressive  dysfunction  of
he  cerebrovascular  regulation  mechanisms  can  cause  dam-
ge  to  the  blood-brain  barrier:  in  these  cases,  MRI  with
adolinium  injection  shows  enhancement  on  T1-weighted
mages  [13]. Equally,  a  cytotoxic  oedema  may  appear,
hich  would  show  a  decreased  diffusion  coefﬁcient,  as
n  the  case  described  by  Benziada-Boudour  et  al.  [14].
n  these  cases  that  have  progressed  further,  haemorrhage
Fig.  4)  may  develop:  this  happens  in  between  5  and  30%
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irietal lobes, occipital lobes and the basal ganglia; c and d: repeat
ions have signiﬁcantly regressed.
f cases,  depending  on  the  study  [1,15,16].  Three  types  of
aemorrhage  have  been  identiﬁed  and  they  have  a  similar
ncidence:  focal  haemorrhage  (<  5  mm),  intra-parenchymal
aematoma  and  sulcal  subarachnoid  haemorrhage.  The  risk
eems  to  be  greater  in  patients  who  have  undergone  allo-
eneic  bone  marrow  transplants  or  organ  transplants,  as  well
s  in  patients  taking  anticoagulants  [16].
rogress
he  patient  very  often  makes  good  clinical  progress
Figs.  4  and  5)  with  clinical  signs  improving  relatively  quickly
nd  radiological  imaging  features  soon  no  longer  evident.
he  condition  is  usually  fully  reversible  although  there
emains  a  risk  of  neurological  sequelae,  or  even  death  [17].
ecurrent  forms  of  PRES  have  been  reported:  these  are  cases
n  which  the  patient’s  blood  pressure  is  not  satisfactorily
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controlled,  or  when  the  patient  needs  to  continue  taking
immunosuppressant  drugs  (for  example,  after  a  transplant)
[2].
Differential diagnosis
The  main  differential  diagnoses  are  [18]:
• acute  cerebral  ischaemia:  unilateral,  systematically
arranged  lesions,  with  a  decreased  diffusion  coefﬁcient
that  points  to  a  cytotoxic  oedema;
• cerebral  venous  thrombosis:  diffuse,  asymmetrical  lesions
that  are  sometimes  complicated  by  secondary  haemor-
rhage  of  the  lesion.  The  diffusion  coefﬁcient  is  raised
initially  but  it  can  then  fall;
• transient  cerebral  hyperaemia:  this  can  develop  after  an
episode  of  epilepsy,  rapid  decompression  of  a  chronic
subdural  haematoma  or  an  endarterectomy.  Diffuse  high
signal  intensity  on  FLAIR  and  T2-weighted  images  point
to  a  vasogenic  oedema  and  the  ADC  (apparent  diffusion
coefﬁcient)  is  raised;
• pontine  encephalopathies  related  to  metabolic  disor-
ders  or  mitochondrial  encephalomyopathy,  lactic  acidosis
and  stroke-like  episodes  (MELAS)  syndrome:  lesions  are
localised  to  the  brain  stem,  and  the  ADC  is  raised;
• autoimmune  encephalitis:  acute  disseminated
encephalomyelitis  (ADEM).  This  condition  has  a  dis-
tinctive  clinical  context,  often  following  a  viral  infection
or  a  vaccination.  The  MRI  may  show  diffuse  high  signal
intensity  on  T2-weighted  images  and  FLAIR  sequences,
which  is  bilateral  but  asymmetrical.  The  ADC  is  vari-
able:  it  can  be  decreased,  normal  or  raised.  There  is
often  lesion  enhancement,  which  may  be  nodular  or
ring-shaped;
• cerebral  oedema  in  a  post-critical  condition  or  after  pro-
longed  hypoxaemia:  diffuse  lesions  and  a  raised  diffusion
coefﬁcient;
• Creutzfeldt-Jakob  disease:  lesions  with  a  raised  diffusion
coefﬁcient,  affecting  the  basal  ganglia  and  the  cerebral
cortex;
• gliomatosis  cerebri:  diffusely  inﬁltrating  glial  tumour  with
iso-intense  or  low  signal  intensity  on  T1-weighted  images
and  high  T2  signal  intensity.  There  is  no  appearance  of
necrosis  or  haemorrhage,  nor  any  initial  contrast  agent
take-up.  When  present  in  one  or  several  lobes,  this  is  sug-
gestive  of  this  diagnosis,  but  when  present  in  isolation
in  the  brain  stem,  diagnosis  can  be  misled.  Spectroscopy
demonstrates  a  tumour-type  proﬁle  with  an  increased
choline/NAA  ratio,  and  marked  elevation  of  myo-inositol;
• progressive  multifocal  leukoencephalopathy,  against  a
background  of  immunosuppression:  high  signal  intensity
on  T2-weighted  images  and  FLAIR  sequences,  non-
enhancing  on  T1-weighted  images  after  injection  of
gadolinium  chelates,  involving  predominantly  the  sub-
cortical  white  matter  (short  ﬁbres)  or  the  parietal  and
occipital  regions.  There  may  be  single  or  multiple  lesions,
which  may  be  unilateral  or  bilateral  and  asymmetrical.Conclusion
PRES  refers  to  a  radiological  and  clinical  syndrome  that  is
characterised  by  a  range  of  neurological  signs  appearing
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n  association  with  abnormalities  of  the  white  matter  and
he  grey  matter  predominantly  affecting  the  posterior
egions.  The  distinctive  clinical  context  as  well  as  the  quick
eversibility  of  the  clinical  and  radiological  abnormalities
s  suggestive  of  cerebral  vasogenic  oedema  secondary  to
asculopathy.  Imaging,  especially  MRI,  plays  an  essential
ole  in  diagnosing  this  condition  that  radiologists  and  clini-
ians  should  be  well  aware  of.  The  extent  of  reversibility
epends  on  how  quickly  diagnosis  is  made  and  how  soon
he  factors  favouring  development  are  addressed.  Moreover,
n  understanding  of  this  syndrome  must  encourage  practi-
ioners  not  to  conduct  unnecessary  repeat  imaging  when  a
atient  makes  good  clinical  progress.
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